Demographic of the study participants, urinary arsenic species and IL-17A cytokine. by Faruque Parvez (13136)

Subjects:

Association between urinary arsenic species and IL-17A cytokine production stratified by low and high Vitamin D levels. by Faruque Parvez (13136)

Subjects:

Introgression decreases allelic shuffling. by Enrique J. Schwarzkopf (6579275)

Patient interest in participating in care tasks. by Chava Kurtz (21519468)

“…A larger proportion of patients who were not interested in participation were from community-based units (75.7%), compared to those who expressed at least some interest (61%).…”

The p53-MDM2 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

The p53-Peptide 1 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Growth on stiff substrate results in mild lifespan extension but a decrease in organismal health. by Maria Oorloff (19658113)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

MST1 upregulates CD36 expression via PPARγ. by Jianyang Li (461703)

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

TITAN decreaser diatom heatmap. by Brent J. Bellinger (21156150)

Pirk-like knockdown decreased egg production. by Mao Wang (115790)

SHAP dependence plots for four most influential decreasing gait parameters via RF model. by Mohammad Pourmahmood Aghababa (18290996)

Development of a Highly Efficient NIR-II Phototherapeutic Agent for Fluorescence Imaging-Guided Synergistic PTT/PDT/Chemotherapy of Colorectal Cancer by Ji Liu (110659)

“…To decrease thermal resistance during phototherapy, IRF and evodiamine (EVO) were loaded onto hyaluronic acid (HA)-modified nanoparticles, creating a multifunctional nanoplatform termed EVO/IRF@HA NPs. …”

Image_2_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_3_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Inhibition of CREB via 666–15 in the presence of PMA resulted in a further decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

Image_14_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_13_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)